Acelarin First Line Randomised Pancreatic Study
Clinical trial NCT03610100 · SUSPENDED
Trial details
- NCT number
- NCT03610100
- Sponsor
- The Clatterbridge Cancer Centre NHS Foundation Trust
- Status
- SUSPENDED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2020-09-01
- Enrollment
- 328
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.